Aripiprazole is a brand-to-generic collapse that already happened, and the numbers are stark. Medicare Part D covered 3,844,727 generic aripiprazole claims for 647,122 people in 2024 at an average of $63.80 per claim, against 7,139 remaining brand Abilify claims at $991.08 each. Same molecule, 15 times the price, and 99.8% of the volume has already moved.
But “Abilify” now covers four different products at four wildly different prices, and only one of them has a generic. The oral tablet is cheap. The long-acting injections, Abilify Maintena and Abilify Asimtufii, are brand-only and cost more per shot than a year of the pills. Every figure below was researched on September 4, 2026.
What Does Abilify Cost Without Insurance?
Acquisition costs come from the CMS National Average Drug Acquisition Cost survey, every row effective August 19, 2026. That is what a pharmacy pays a wholesaler, not what you pay at the counter. Cash prices come from Drugs.com and HealthWarehouse, both read September 4, 2026. Medicare Part D figures are 2024 claims data. The Abilify Asimtufii row is calculated from the CMS per-millilitre acquisition cost times the presentation volume, because that product is priced per millilitre in the federal file.
| Option | Low | Average | High |
|---|---|---|---|
| CMS NADAC acquisition cost, one generic tablet | $0.10341 (2 mg) | $0.12506 (15 mg) | $0.16732 (20 mg) |
| Cash price, 30 generic tablets, Drugs.com | $6.68 (5 mg) | $9.70 (15 mg) | $15.21 (30 mg) |
| Cash price, 30 generic 5 mg tablets, HealthWarehouse | $18.30 | $18.30 | $18.30 |
| Cash price, 90 generic tablets, Drugs.com | $28.95 (20 mg) | $34.25 (5 mg) | $37.13 (30 mg) |
| Cash price, 30 generic orally disintegrating tablets | $387.04 (10 mg) | $387.04 | $387.04 (15 mg) |
| Cash price, 150 mL generic oral solution | $226.55 | $226.55 | $250.28 |
| CMS NADAC acquisition cost, one brand Abilify tablet | $18.62500 (10 mg) | $18.65276 (2 mg) | $26.25841 (20 mg) |
| Brand Abilify, 30 tablets | $578.16 (2-15 mg) | $578.16 | $814.30 (20 and 30 mg) |
| Abilify Maintena, one monthly injection | $2,199.53 (300 mg) | $2,199.53 | $2,930.06 (400 mg) |
| Abilify Asimtufii, one two-month injection (CMS-derived) | $4,285.58 (720 mg) | $4,285.58 | $5,707.99 (960 mg) |
| Medicare Part D average spending per claim, 2024 | $63.80 (generic) | $991.08 (brand Abilify) | $5,433.10 (Asimtufii) |
The sources disagree sharply at the cheap end, and the disagreement is the point. Drugs.com puts 30 of the 5 mg generic tablets at $6.68 while HealthWarehouse, a licensed mail-order pharmacy publishing real transactable prices, puts the identical fill at $18.30. Both are legitimate published cash prices read the same day. Treat the range as $7 to $18 for a 30-day fill, and treat the gap as the reason to call more than one pharmacy.
The federal acquisition data explains why that spread exists. Thirty generic tablets contain between $3.10 and $5.02 of actual medicine at wholesale. Everything above that is dispensing fee and pharmacy margin, and different pharmacies set that differently on a bill this small.
What Drives the Price
Generic versus brand, which is a 30x to 90x decision on the tablet. Thirty tablets of generic aripiprazole cost between $6.68 and $18.30. Thirty tablets of brand Abilify cost $578.16 or $814.30. There is no difference in the molecule and the brand holds 0.2% of Part D claims. If a prescription is written for brand Abilify at a pharmacy counter and you are paying cash, that is a question worth raising with the prescriber before you fill it.
Oral versus long-acting injection, which is a different question entirely. Abilify Maintena and Abilify Asimtufii are brand-only, have no generic, and are given in a clinic rather than picked up at a pharmacy. Maintena is Otsuka’s once-monthly formulation and Asimtufii the once-every-two-months version, per Otsuka’s own product site. At CMS acquisition cost, Maintena runs $2,138.91 to $2,856.92 per injection and Asimtufii works out to roughly $4,286 to $5,708 per injection, which is about $2,143 to $2,854 per month either way. The two products are priced to be near-identical on a monthly basis. Neither is a shopping decision, and switching between long-acting and oral is a clinical one, not a budget one.
The orally disintegrating tablet is a trap. This is the strangest line on the page. FDA lists every strength of Abilify Discmelt, the brand disintegrating tablet, as discontinued, and generic supply behind it is thin. The result is that the generic disintegrating 10 mg tablet costs a pharmacy $2.41913 against $0.10488 for the ordinary 10 mg tablet on the same day, and retails at $387.04 for 30 against $8.62. Medicare Part D paid $636.72 per disintegrating claim in 2024 against $63.80 for the ordinary generic. Only the 10 mg and 15 mg disintegrating strengths appear in the federal file at all. If a prescription lands on the disintegrating form for convenience rather than necessity, it is worth asking what the ordinary tablet would cost.
The oral solution is the same story, milder. Brand Abilify oral solution is also discontinued per FDA records, and the surviving generic costs $0.31307 per millilitre at wholesale but $226.55 to $250.28 for a 150 mL bottle at retail. That is a five-fold markup over acquisition, against roughly two-fold on the ordinary tablets.
Strength, which almost does not matter and then suddenly does. Generic aripiprazole barely moves across the dose range: $0.10341 per tablet at 2 mg and $0.16732 at 20 mg, a 1.6x spread across a ten-fold dose range, and the 20 mg row is actually a hair above the 30 mg row at $0.16456. Brand Abilify behaves differently, with a clean two-tier structure: $18.63 to $18.71 per tablet at 2 mg through 15 mg, then a 41% jump to $26.24 and $26.26 at 20 mg and 30 mg. On the generic, a dose increase will not meaningfully change your bill. On the brand, crossing 20 mg will.
Cash Price vs. Insurance
For the generic tablet, cash usually wins. A $7 to $18 fill beats most plans’ $10 or $15 generic copay outright and never touches your pharmacy benefit. The tradeoff is standard: money spent outside a plan does not count toward your deductible or out-of-pocket maximum, and you cannot stack a discount card with insurance on the same fill. On a drug this cheap that lost credit rarely matters. Our quetiapine and Seroquel guide and lamotrigine guide reach the same conclusion for the same reason.
For everything else in the Abilify family, cash loses badly. Brand Abilify at $578 to $814 a month, Maintena at $2,200 to $2,930 a shot and Asimtufii at $4,286 to $5,708 a shot are all products where insurance, and failing that a patient assistance program, is the only realistic route. Note also that the long-acting injections are usually billed as a clinic-administered drug rather than a pharmacy fill, which means the administration visit shows up as a separate charge on a separate bill.
If a pharmacy quotes you a triple-digit number for ordinary generic aripiprazole tablets, that is a contract artifact rather than the price of the medicine. Run it through our fair price checker and then call a second pharmacy.
How to Pay Less
-
Call two pharmacies, because this drug’s spread is between sellers, not between doses. A 2.7x gap between two published cash prices on the same 30-tablet fill of 5 mg tablets, on the same day, is the largest single lever on this page. Mail order is often but not always the cheaper side: here it was the more expensive one.
-
Do not assume aripiprazole is on the Walmart program list, because it is not. We read every tier of Walmart’s prescription program drug list, effective March 24, 2025 and linked from the program page, on September 4, 2026. Aripiprazole appears nowhere, at any price. Quetiapine, risperidone, buspirone, lamotrigine, lithium, sertraline, fluoxetine, citalopram, paroxetine, mirtazapine and trazodone are all on it, so it is easy to assume aripiprazole is too. Ask the pharmacy for their actual cash price instead of expecting a program rate.
-
Run a free discount card before every fill. On a drug where the acquisition cost is under $5 for a month, almost the entire counter price is negotiable margin, and a card is the fastest way to reach it. Our comparison of GoodRx vs. SingleCare explains how to price the same prescription both ways and why an online quote can move between visits.
-
Fill 90 days at a time. Aripiprazole is not a federally scheduled controlled substance, so long supplies and mail order are genuinely available, and every route charges its fixed costs per fill rather than per pill. Drugs.com’s 90-count prices run $28.95 to $37.13, which is $9.65 to $12.38 a month against $6.68 to $15.21 for a 30-count, and the saving is larger at the higher strengths.
-
For the injections, go to the Otsuka Patient Assistance Foundation. OPAF is an independent 501(c)(3) that provides free medication to eligible uninsured and underinsured patients, and its supported-medications list names Abilify Maintena and Abilify Asimtufii explicitly, alongside Rexulti (see our Rexulti cost guide). Standard non-government enrollment can supply free medicine for a rolling 12 months from approval. Applications require proof of household gross income and proof of a US address but not US citizenship, and the phone line is 1-855-727-6274. Note that OPAF publishes documentation requirements rather than a stated income cutoff, so call rather than self-disqualifying.
-
Know that the manufacturer savings cards will not help a cash payer here. Drugs.com records the Abilify savings card as available to eligible commercially insured patients at $5 per 30-day supply, expiring December 31, 2026, and the Abilify Maintena card as $0 per month for eligible commercially insured patients with a maximum of $1,400 per fill and $8,000 per year. Both exclude the uninsured. That is the usual pattern, though not a universal one: our Caplyta cost guide documents a trial offer that does cover cash payers.
-
Budget for the prescriber visit, not just the pills. On generic aripiprazole the appointment costs far more than the medication. Our psychiatrist cost guide covers what those visits run, a free or sliding-scale clinic can often handle refills at little or no cost, and if an injection bill has already landed, our guide to negotiating medical bills covers what to do next.
Bottom Line
Budget $7 to $18 a month for generic aripiprazole tablets at any strength, or about $10 to $12 a month if you fill 90 days at a time. Anything above roughly $50 for a 30-day generic fill is a reason to shop rather than a fact about the drug.
The expensive versions are the ones people do not expect. Brand Abilify runs $578 to $814 for 30 tablets, the orally disintegrating generic runs $387 for 30 because the brand version of that form was discontinued, the oral solution runs $227 to $250 for 150 mL, and the long-acting injections run $2,200 to $2,930 per monthly shot or roughly $4,286 to $5,708 per two-month shot. Two of those, the disintegrating tablet and the solution, are usually worth a conversation with the prescriber about whether the ordinary tablet would do. The injections are not a shopping problem at all, they are a patient-assistance problem, and Otsuka’s foundation is the place to start.